| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.935 | 0.004 | 0.941 | Transcription factor NF kappa B inhibitor | 0.928 0.004 DBMET02434 0.874 0.008 DBMET02436 0.935 0.004 DBMET02437 0.941 0.003 DBMET02438 0.916 0.005 DBMET02435 | DBMET02438 | |
| 0.9 | 0.005 | 0.913 | Antiinflammatory | 0.893 0.005 DBMET02434 0.913 0.005 DBMET02436 0.9 0.005 DBMET02437 0.907 0.005 DBMET02438 0.9 0.005 DBMET02435 | DBMET02436 | |
| 0.892 | 0.004 | 0.925 | Immunomodulator | 0.892 0.004 DBMET02434 0.84 0.004 DBMET02436 0.892 0.004 DBMET02437 0.819 0.004 DBMET02438 0.925 0.003 DBMET02435 | DBMET02435 | |
| 0.87 | 0.009 | 0.87 | Apoptosis agonist | 0.768 0.021 DBMET02434 0.798 0.017 DBMET02436 0.87 0.009 DBMET02437 0.812 0.015 DBMET02438 0.758 0.022 DBMET02435 | ||
| 0.705 | 0.008 | 0.705 | Cholesterol antagonist | 0.679 0.01 DBMET02434 0.648 0.013 DBMET02436 0.705 0.008 DBMET02437 0.49 0.034 DBMET02438 0.594 0.019 DBMET02435 | ||
| 0.695 | 0 | 0.961 | Vitamin D receptor agonist | 0.921 0 DBMET02434 0.84 0 DBMET02436 0.695 0 DBMET02437 0.331 0 DBMET02438 0.961 0 DBMET02435 | DBMET02435 | |
| 0.675 | 0.006 | 0.701 | Immunosuppressant | 0.644 0.008 DBMET02434 0.651 0.007 DBMET02436 0.675 0.006 DBMET02437 0.661 0.007 DBMET02438 0.701 0.005 DBMET02435 | DBMET02435 | |
| 0.664 | 0.007 | 0.664 | Nitric oxide antagonist | 0.592 0.01 DBMET02434 0.589 0.01 DBMET02436 0.664 0.007 DBMET02437 0.589 0.01 DBMET02438 0.574 0.011 DBMET02435 | ||
| 0.642 | 0.002 | 0.747 | Interferon gamma antagonist | 0.678 0.001 DBMET02434 0.698 0.001 DBMET02436 0.642 0.002 DBMET02437 0.614 0.002 DBMET02438 0.747 0.001 DBMET02435 | DBMET02435 | |
| 0.642 | 0.004 | 0.828 | Interleukin agonist | 0.711 0.003 DBMET02434 0.717 0.003 DBMET02436 0.642 0.004 DBMET02437 0.416 0.017 DBMET02438 0.828 0.002 DBMET02435 | DBMET02435 | |
| 0.575 | 0.001 | 0.721 | Vitamin D receptor antagonist | 0.583 0.001 DBMET02434 0.559 0.001 DBMET02436 0.575 0.001 DBMET02437 0.389 0.001 DBMET02438 0.721 0 DBMET02435 | DBMET02435 | |
| 0.56 | 0.001 | 0.881 | Parathyroid hormone antagonist | 0.799 0 DBMET02434 0.49 0.001 DBMET02436 0.56 0.001 DBMET02437 0.323 0.001 DBMET02438 0.881 0 DBMET02435 | DBMET02435 | |
| 0.561 | 0.004 | 0.652 | Bone formation stimulant | 0.636 0.003 DBMET02434 0.531 0.005 DBMET02436 0.561 0.004 DBMET02437 0.513 0.005 DBMET02438 0.652 0.003 DBMET02435 | DBMET02435 | |
| 0.566 | 0.013 | 0.566 | Caspase 3 stimulant | 0.393 0.047 DBMET02434 0.341 0.062 DBMET02436 0.566 0.013 DBMET02437 0.445 0.031 DBMET02438 0.326 0.067 DBMET02435 | ||
| 0.535 | 0.001 | 0.537 | CYP24 inhibitor | 0.483 0.001 DBMET02434 0.487 0.001 DBMET02436 0.535 0.001 DBMET02437 0.429 0.001 DBMET02438 0.537 0.001 DBMET02435 | DBMET02435 | |
| 0.521 | 0 | 0.983 | Vitamin D-like | 0.894 0 DBMET02434 0.304 0 DBMET02436 0.521 0 DBMET02437 0.393 0 DBMET02438 0.983 0 DBMET02435 | DBMET02435 | |
| 0.49 | 0.013 | 0.49 | Hypolipemic | 0.433 0.02 DBMET02434 0.448 0.018 DBMET02436 0.49 0.013 DBMET02437 0.398 0.025 DBMET02438 0.426 0.021 DBMET02435 | ||
| 0.482 | 0.006 | 0.544 | Calcium channel activator | 0.487 0.006 DBMET02434 0.505 0.005 DBMET02436 0.482 0.006 DBMET02437 0.437 0.014 DBMET02438 0.544 0.004 DBMET02435 | DBMET02435 | |
| 0.472 | 0.005 | 0.472 | Sodium/bile acid cotransporter inhibitor | 0.462 0.006 DBMET02434 0.464 0.006 DBMET02436 0.472 0.005 DBMET02437 0.423 0.012 DBMET02438 0.451 0.007 DBMET02435 | ||
| 0.466 | 0.004 | 0.514 | Androgen antagonist | 0.464 0.004 DBMET02434 0.484 0.004 DBMET02436 0.466 0.004 DBMET02437 0.514 0.004 DBMET02438 0.33 0.006 DBMET02435 | DBMET02438 | |
| 0.447 | 0.005 | 0.447 | Interleukin 4 antagonist | 0.206 0.021 DBMET02434 0.173 0.033 DBMET02436 0.447 0.005 DBMET02437 0.33 0.007 DBMET02438 0.186 0.027 DBMET02435 | ||
| 0.482 | 0.046 | 0.507 | Antibacterial | 0.353 0.1 DBMET02434 0.507 0.039 DBMET02436 0.482 0.046 DBMET02437 0.31 0.128 DBMET02438 0.366 0.093 DBMET02435 | DBMET02436 | |
| 0.437 | 0.003 | 0.437 | Pregnane X receptor agonist | 0.37 0.003 DBMET02434 0.228 0.006 DBMET02436 0.437 0.003 DBMET02437 0.19 0.014 DBMET02438 0.341 0.004 DBMET02435 | ||
| 0.44 | 0.01 | 0.669 | Non-steroidal antiinflammatory agent | 0.481 0.007 DBMET02434 0.523 0.006 DBMET02436 0.44 0.01 DBMET02437 0.397 0.014 DBMET02438 0.669 0.004 DBMET02435 | DBMET02435 | |
| 0.453 | 0.065 | 0.516 | Cyclophilin D inhibitor | 0.393 0.095 DBMET02434 0.516 0.046 DBMET02436 0.453 0.065 DBMET02437 0.243 0.222 DBMET02438 0.403 0.089 DBMET02435 | DBMET02436 | |
| 0.419 | 0.032 | 0.419 | Antioxidant | 0.336 0.05 DBMET02434 0.363 0.043 DBMET02436 0.419 0.032 DBMET02437 0.37 0.041 DBMET02438 0.319 0.055 DBMET02435 | ||
| 0.386 | 0.004 | 0.386 | Farnesoid X receptor antagonist | 0.354 0.004 DBMET02434 0.342 0.004 DBMET02436 0.386 0.004 DBMET02437 0.287 0.007 DBMET02438 0.365 0.004 DBMET02435 | ||
| 0.394 | 0.014 | 0.394 | Hepatoprotectant | 0.334 0.022 DBMET02434 0.37 0.016 DBMET02436 0.394 0.014 DBMET02437 0.328 0.023 DBMET02438 0.315 0.026 DBMET02435 | ||
| 0.413 | 0.046 | 0.471 | Immunostimulant | 0.413 0.046 DBMET02434 0.471 0.033 DBMET02436 0.413 0.046 DBMET02437 0.32 0.073 DBMET02438 0.338 0.068 DBMET02435 | DBMET02436 | |
| 0.395 | 0.028 | 0.395 | Tumour necrosis factor alpha release inhibitor | 0.299 0.054 DBMET02434 0.356 0.036 DBMET02436 0.395 0.028 DBMET02437 0.3 0.053 DBMET02438 0.289 0.058 DBMET02435 | ||
| 0.373 | 0.007 | 0.373 | DNA polymerase I inhibitor | 0.303 0.011 DBMET02434 0.261 0.015 DBMET02436 0.373 0.007 DBMET02437 0.245 0.018 DBMET02438 0.273 0.014 DBMET02435 | ||
| 0.356 | 0.005 | 0.356 | Neurotrophic factor | 0.227 0.017 DBMET02434 0.226 0.018 DBMET02436 0.356 0.005 DBMET02437 0.221 0.019 DBMET02438 0.235 0.015 DBMET02435 | ||
| 0.388 | 0.042 | 0.388 | Apoptosis antagonist | 0.373 0.046 DBMET02434 0.359 0.052 DBMET02436 0.388 0.042 DBMET02437 0.298 0.087 DBMET02438 0.348 0.057 DBMET02435 | ||
| 0.329 | 0.003 | 0.329 | CDC25A inhibitor | 0.289 0.004 DBMET02434 0.259 0.004 DBMET02436 0.329 0.003 DBMET02437 0.219 0.005 DBMET02438 0.221 0.005 DBMET02435 | ||
| 0.329 | 0.009 | 0.332 | Cholesterol synthesis inhibitor | 0.332 0.008 DBMET02434 0.323 0.009 DBMET02436 0.329 0.009 DBMET02437 0.23 0.021 DBMET02438 0.312 0.01 DBMET02435 | DBMET02434 | |
| 0.306 | 0.02 | 0.449 | Lipocortins synthesis antagonist | 0.307 0.02 DBMET02434 0.307 0.02 DBMET02436 0.306 0.02 DBMET02437 0.449 0.005 DBMET02438 0.284 0.024 DBMET02435 | DBMET02438 | |
| 0.389 | 0.117 | 0.493 | Caspase 9 stimulant | 0.431 0.093 DBMET02434 0.493 0.063 DBMET02436 0.389 0.117 DBMET02437 0.35 0.145 DBMET02438 0.332 0.161 DBMET02435 | DBMET02436 | |
| 0.256 | 0.005 | 0.478 | Keratolytic | 0.278 0.004 DBMET02434 0.296 0.004 DBMET02436 0.256 0.005 DBMET02437 0.169 0.012 DBMET02438 0.478 0.002 DBMET02435 | DBMET02435 | |
| 0.255 | 0.007 | 0.269 | Microtubule formation inhibitor | 0.265 0.005 DBMET02434 0.269 0.004 DBMET02436 0.255 0.007 DBMET02437 0.244 0.01 DBMET02438 0.269 0.004 DBMET02435 | DBMET02435 | |
| 0.255 | 0.014 | 0.293 | Antineoplastic antibiotic | 0.282 0.011 DBMET02434 0.227 0.017 DBMET02436 0.255 0.014 DBMET02437 0.226 0.017 DBMET02438 0.293 0.01 DBMET02435 | DBMET02435 | |
| 0.285 | 0.055 | 0.313 | Angiogenesis stimulant | 0.296 0.051 DBMET02434 0.313 0.045 DBMET02436 0.285 0.055 DBMET02437 0.19 0.1 DBMET02438 0.287 0.054 DBMET02435 | DBMET02436 | |
| 0.295 | 0.077 | 0.295 | Interleukin 2 agonist | 0.278 0.091 DBMET02434 0.269 0.099 DBMET02436 0.295 0.077 DBMET02437 0.268 0.1 DBMET02438 0.244 0.126 DBMET02435 | ||
| 0.219 | 0.004 | 0.219 | 5-Alpha-reductase inhibitor | 0.192 0.005 DBMET02434 0.148 0.007 DBMET02436 0.219 0.004 DBMET02437 0.093 0.01 DBMET02438 0.149 0.007 DBMET02435 | ||
| 0.214 | 0.008 | 0.281 | ABCA1 expression enhancer | 0.222 0.008 DBMET02434 0.218 0.008 DBMET02436 0.214 0.008 DBMET02437 0.135 0.022 DBMET02438 0.281 0.005 DBMET02435 | DBMET02435 | |
| 0.211 | 0.007 | 0.211 | Inducible nitric-oxide synthase inhibitor | 0.084 0.056 DBMET02434 0.211 0.007 DBMET02437 0.096 0.041 DBMET02438 0.094 0.042 DBMET02435 | ||
| 0.198 | 0.004 | 0.225 | Anabolic | 0.209 0.003 DBMET02434 0.217 0.003 DBMET02436 0.198 0.004 DBMET02437 0.219 0.003 DBMET02438 0.225 0.002 DBMET02435 | DBMET02435 | |
| 0.217 | 0.036 | 0.217 | Protein kinase stimulant | 0.146 0.071 DBMET02434 0.133 0.081 DBMET02436 0.217 0.036 DBMET02437 0.209 0.038 DBMET02438 0.108 0.107 DBMET02435 | ||
| 0.201 | 0.029 | 0.201 | Protein-tyrosine phosphatase 1B inhibitor | 0.134 0.053 DBMET02434 0.156 0.043 DBMET02436 0.201 0.029 DBMET02437 0.103 0.075 DBMET02438 0.128 0.057 DBMET02435 | ||
| 0.201 | 0.032 | 0.208 | Arachidonic acid antagonist | 0.194 0.039 DBMET02434 0.183 0.05 DBMET02436 0.201 0.032 DBMET02437 0.208 0.025 DBMET02438 0.178 0.056 DBMET02435 | DBMET02438 | |
| 0.21 | 0.043 | 0.21 | Protein-tyrosine phosphatase inhibitor | 0.14 0.09 DBMET02434 0.153 0.075 DBMET02436 0.21 0.043 DBMET02437 0.132 0.099 DBMET02435 | ||
| 0.175 | 0.011 | 0.175 | Interleukin 2 antagonist | 0.175 0.011 DBMET02437 0.128 0.034 DBMET02438 | ||
| 0.231 | 0.069 | 0.231 | Interleukin antagonist | 0.231 0.069 DBMET02437 0.22 0.074 DBMET02438 0.165 0.107 DBMET02435 | ||
| 0.163 | 0.004 | 0.163 | Na+ K+ transporting ATPase inhibitor | 0.16 0.004 DBMET02434 0.162 0.004 DBMET02436 0.163 0.004 DBMET02437 0.14 0.008 DBMET02438 0.154 0.005 DBMET02435 | ||
| 0.152 | 0.007 | 0.152 | Bile acid receptor antagonist | 0.127 0.014 DBMET02434 0.114 0.026 DBMET02436 0.152 0.007 DBMET02437 0.091 0.072 DBMET02438 0.107 0.035 DBMET02435 | ||
| 0.147 | 0.01 | 0.269 | T cell inhibitor | 0.143 0.01 DBMET02434 0.149 0.01 DBMET02436 0.147 0.01 DBMET02437 0.148 0.01 DBMET02438 0.269 0.005 DBMET02435 | DBMET02435 | |
| 0.273 | 0.136 | 0.428 | Antiobesity | 0.281 0.13 DBMET02434 0.428 0.056 DBMET02436 0.273 0.136 DBMET02437 0.229 0.177 DBMET02435 | DBMET02436 | |
| 0.137 | 0.004 | 0.137 | Liver X receptor alpha agonist | 0.088 0.006 DBMET02434 0.056 0.015 DBMET02436 0.137 0.004 DBMET02437 0.056 0.015 DBMET02435 | ||
| 0.124 | 0.005 | 0.124 | Liver X receptor agonist | 0.081 0.01 DBMET02434 0.067 0.014 DBMET02436 0.124 0.005 DBMET02437 0.048 0.024 DBMET02438 0.071 0.013 DBMET02435 | ||
| 0.174 | 0.058 | 0.174 | Diuretic | 0.174 0.058 DBMET02437 0.118 0.106 DBMET02438 | ||
| 0.153 | 0.057 | 0.153 | Adenylate cyclase stimulant | 0.143 0.075 DBMET02434 0.126 0.111 DBMET02436 0.153 0.057 DBMET02437 0.15 0.063 DBMET02438 | ||
| 0.105 | 0.009 | 0.283 | Progesterone antagonist | 0.143 0.006 DBMET02434 0.123 0.007 DBMET02436 0.105 0.009 DBMET02437 0.153 0.006 DBMET02438 0.283 0.004 DBMET02435 | DBMET02435 | |
| 0.142 | 0.047 | 0.15 | Vanilloid 1 agonist | 0.15 0.038 DBMET02434 0.123 0.08 DBMET02436 0.142 0.047 DBMET02437 0.12 0.087 DBMET02438 0.129 0.068 DBMET02435 | DBMET02434 | |
| 0.178 | 0.088 | 0.256 | Anesthetic general | 0.256 0.048 DBMET02434 0.228 0.06 DBMET02436 0.178 0.088 DBMET02437 0.159 0.105 DBMET02435 | DBMET02434 | |
| 0.155 | 0.067 | 0.164 | NOS3 expression enhancer | 0.133 0.092 DBMET02434 0.155 0.067 DBMET02437 0.164 0.06 DBMET02438 | DBMET02438 | |
| 0.111 | 0.023 | 0.111 | Vanilloid agonist | 0.109 0.025 DBMET02434 0.078 0.075 DBMET02436 0.111 0.023 DBMET02437 0.099 0.034 DBMET02438 0.099 0.034 DBMET02435 | ||
| 0.204 | 0.116 | 0.25 | DNA synthesis inhibitor | 0.217 0.099 DBMET02434 0.198 0.126 DBMET02436 0.204 0.116 DBMET02437 0.25 0.067 DBMET02438 0.171 0.166 DBMET02435 | DBMET02438 | |
| 0.097 | 0.023 | 0.123 | Glycine receptor agonist | 0.123 0.012 DBMET02434 0.096 0.024 DBMET02436 0.097 0.023 DBMET02437 0.066 0.064 DBMET02438 0.092 0.026 DBMET02435 | DBMET02434 | |
| 0.137 | 0.068 | 0.184 | Interleukin 1 antagonist | 0.138 0.068 DBMET02434 0.133 0.072 DBMET02436 0.137 0.068 DBMET02437 0.184 0.04 DBMET02435 | DBMET02435 | |
| 0.139 | 0.07 | 0.153 | Amylase inhibitor | 0.106 0.091 DBMET02434 0.153 0.063 DBMET02436 0.139 0.07 DBMET02437 0.1 0.096 DBMET02435 | DBMET02436 | |
| 0.071 | 0.009 | 0.103 | RNA-directed RNA polymerase stimulant | 0.063 0.011 DBMET02434 0.063 0.011 DBMET02436 0.071 0.009 DBMET02437 0.103 0.006 DBMET02438 0.048 0.014 DBMET02435 | DBMET02438 | |
| 0.077 | 0.018 | 0.077 | Heme oxygenase stimulant | 0.072 0.023 DBMET02434 0.072 0.023 DBMET02436 0.077 0.018 DBMET02437 0.075 0.019 DBMET02438 0.07 0.025 DBMET02435 | ||
| 0.075 | 0.017 | 0.096 | Lipocortins synthesis agonist | 0.075 0.017 DBMET02434 0.073 0.018 DBMET02436 0.075 0.017 DBMET02437 0.096 0.006 DBMET02438 0.073 0.019 DBMET02435 | DBMET02438 | |
| 0.078 | 0.02 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.078 0.02 DBMET02434 0.076 0.021 DBMET02436 0.078 0.02 DBMET02437 0.083 0.018 DBMET02438 0.066 0.026 DBMET02435 | DBMET02438 | |
| 0.061 | 0.005 | 0.07 | HMG CoA reductase inhibitor | 0.061 0.005 DBMET02434 0.07 0.004 DBMET02436 0.061 0.005 DBMET02437 0.049 0.008 DBMET02438 0.06 0.005 DBMET02435 | DBMET02436 | |
| 0.061 | 0.009 | 0.099 | Farnesoid X receptor agonist | 0.065 0.008 DBMET02434 0.099 0.004 DBMET02436 0.061 0.009 DBMET02437 0.039 0.025 DBMET02435 | DBMET02436 | |
| 0.062 | 0.012 | 0.065 | Microtubule stabilization | 0.064 0.01 DBMET02434 0.064 0.01 DBMET02436 0.062 0.012 DBMET02437 0.06 0.014 DBMET02438 0.065 0.009 DBMET02435 | DBMET02435 | |
| 0.078 | 0.03 | 0.078 | CDC25B inhibitor | 0.073 0.035 DBMET02434 0.064 0.046 DBMET02436 0.078 0.03 DBMET02437 0.061 0.048 DBMET02435 | ||
| 0.074 | 0.028 | 0.098 | Androgen agonist | 0.097 0.016 DBMET02434 0.085 0.022 DBMET02436 0.074 0.028 DBMET02437 0.098 0.015 DBMET02438 0.065 0.035 DBMET02435 | DBMET02438 | |
| 0.046 | 0.007 | 0.046 | 5-Alpha-reductase 2 inhibitor | 0.035 0.008 DBMET02434 0.046 0.007 DBMET02437 | ||
| 0.049 | 0.012 | 0.049 | Glucose-6-phosphate dehydrogenase inhibitor | 0.046 0.014 DBMET02434 0.046 0.014 DBMET02436 0.049 0.012 DBMET02437 0.046 0.014 DBMET02438 0.041 0.02 DBMET02435 | ||
| 0.096 | 0.06 | 0.111 | Interleukin 12 antagonist | 0.1 0.053 DBMET02434 0.101 0.051 DBMET02436 0.096 0.06 DBMET02437 0.111 0.038 DBMET02435 | DBMET02435 | |
| 0.107 | 0.074 | 0.16 | Interleukin 1b antagonist | 0.116 0.066 DBMET02434 0.131 0.054 DBMET02436 0.107 0.074 DBMET02437 0.16 0.034 DBMET02435 | DBMET02435 | |
| 0.139 | 0.107 | 0.206 | Antipruritic | 0.128 0.127 DBMET02434 0.139 0.107 DBMET02437 0.168 0.076 DBMET02438 0.206 0.045 DBMET02435 | DBMET02435 | |
| 0.135 | 0.105 | 0.157 | Melanin inhibitor | 0.154 0.076 DBMET02434 0.149 0.084 DBMET02436 0.135 0.105 DBMET02437 0.157 0.072 DBMET02438 0.153 0.077 DBMET02435 | DBMET02438 | |
| 0.145 | 0.116 | 0.152 | Phospholipase C inhibitor | 0.141 0.127 DBMET02434 0.152 0.101 DBMET02436 0.145 0.116 DBMET02437 | DBMET02436 | |
| 0.156 | 0.128 | 0.172 | Growth factor agonist | 0.156 0.128 DBMET02437 0.172 0.098 DBMET02435 | DBMET02435 | |
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | 0.033 0.009 DBMET02434 0.031 0.011 DBMET02436 0.035 0.007 DBMET02437 0.026 0.022 DBMET02435 | ||
| 0.086 | 0.058 | 0.086 | Transcription factor NF kappa B stimulant | 0.083 0.064 DBMET02434 0.086 0.057 DBMET02436 0.086 0.058 DBMET02437 | ||
| 0.035 | 0.008 | 0.035 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.03 0.009 DBMET02434 0.035 0.008 DBMET02437 0.024 0.012 DBMET02438 | ||
| 0.041 | 0.019 | 0.041 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.037 0.025 DBMET02434 0.041 0.019 DBMET02437 0.034 0.031 DBMET02438 | ||
| 0.039 | 0.017 | 0.039 | Tubulin agonist | 0.037 0.019 DBMET02434 0.038 0.017 DBMET02436 0.039 0.017 DBMET02437 0.035 0.023 DBMET02438 0.035 0.022 DBMET02435 | ||
| 0.053 | 0.034 | 0.107 | Estrogen agonist | 0.045 0.039 DBMET02436 0.053 0.034 DBMET02437 0.107 0.016 DBMET02438 | DBMET02438 | |
| 0.031 | 0.012 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET02434 0.031 0.012 DBMET02437 0.034 0.008 DBMET02438 | DBMET02438 | |
| 0.082 | 0.065 | 0.102 | Ornithine decarboxylase inhibitor | 0.082 0.065 DBMET02437 0.102 0.043 DBMET02438 | DBMET02438 | |
| 0.029 | 0.014 | 0.029 | Retinoid X gamma receptor antagonist | 0.029 0.015 DBMET02434 0.025 0.024 DBMET02436 0.029 0.014 DBMET02437 0.028 0.017 DBMET02438 0.028 0.017 DBMET02435 | ||
| 0.164 | 0.15 | 0.164 | Spasmolytic | 0.164 0.15 DBMET02437 | ||
| 0.09 | 0.077 | 0.09 | Nitric-oxide synthase inhibitor | 0.09 0.077 DBMET02437 | ||
| 0.103 | 0.091 | 0.125 | Estrogen antagonist | 0.103 0.091 DBMET02437 0.125 0.047 DBMET02438 | DBMET02438 | |
| 0.022 | 0.01 | 0.032 | Progesterone receptor B antagonist | 0.023 0.009 DBMET02434 0.023 0.009 DBMET02436 0.022 0.01 DBMET02437 0.032 0.004 DBMET02438 0.025 0.007 DBMET02435 | DBMET02438 | |
| 0.092 | 0.082 | 0.103 | Monophenol monooxygenase inhibitor | 0.092 0.082 DBMET02437 0.103 0.073 DBMET02438 | DBMET02438 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.008 DBMET02434 0.012 0.008 DBMET02436 0.014 0.006 DBMET02437 0.012 0.008 DBMET02435 | ||
| 0.076 | 0.071 | 0.103 | Antineoplastic alkaloid | 0.103 0.046 DBMET02434 0.088 0.056 DBMET02436 0.076 0.071 DBMET02437 0.091 0.054 DBMET02438 0.086 0.058 DBMET02435 | DBMET02434 | |
| 0.02 | 0.016 | 0.031 | Corticosteroid-like | 0.02 0.017 DBMET02434 0.02 0.017 DBMET02436 0.02 0.016 DBMET02437 0.031 0.006 DBMET02438 | DBMET02438 | |
| 0.016 | 0.013 | 0.016 | 5-Alpha-reductase 1 inhibitor | 0.016 0.013 DBMET02437 | ||
| 0.02 | 0.016 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.016 DBMET02437 | ||
| 0.03 | 0.027 | 0.086 | Estrogen receptor alpha agonist | 0.03 0.027 DBMET02437 0.086 0.011 DBMET02438 | DBMET02438 | |
| 0.138 | 0.135 | 0.177 | P-glycoprotein inhibitor | 0.146 0.124 DBMET02434 0.177 0.082 DBMET02436 0.138 0.135 DBMET02437 0.158 0.105 DBMET02438 0.152 0.114 DBMET02435 | DBMET02436 | |
| 0.148 | 0.147 | 0.148 | Free radical scavenger | 0.148 0.147 DBMET02436 0.148 0.147 DBMET02437 | ||
| 0.014 | 0.016 | 0.036 | Progesterone agonist | 0.036 0.006 DBMET02438 | DBMET02438 | |
| 0.079 | 0.082 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.076 DBMET02436 | DBMET02436 | |
| 0.043 | 0.054 | 0.069 | Aromatase inhibitor | 0.069 0.035 DBMET02438 | DBMET02438 | |
| 0.079 | 0.097 | 0.101 | Expectorant | 0.101 0.068 DBMET02436 | DBMET02436 | |
| 0.016 | 0.042 | 0.03 | Squalene synthetase inhibitor | 0.03 0.024 DBMET02438 | DBMET02438 | |
| 0.013 | 0.039 | 0.032 | Estrogen receptor beta agonist | 0.032 0.023 DBMET02438 | DBMET02438 | |
| 0.015 | 0.042 | 0.024 | Prostaglandin F2 alpha agonist | 0.024 0.014 DBMET02436 | DBMET02436 | |
| 0.016 | 0.046 | 0.077 | Glucocorticoid antagonist | 0.077 0.007 DBMET02438 | DBMET02438 | |
| 0.134 | 0.165 | 0.158 | Neurotrophic factor enhancer | 0.158 0.127 DBMET02434 0.151 0.137 DBMET02436 | DBMET02434 | |
| 0.004 | 0.047 | 0.021 | Glucocorticoid agonist | 0.021 0.007 DBMET02438 | DBMET02438 | |
| 0.013 | 0.056 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.026 0.021 DBMET02436 | DBMET02436 | |
| 0.118 | 0.165 | 0.155 | Antimitotic | 0.155 0.117 DBMET02435 | DBMET02435 | |
| 0.069 | 0.126 | 0.093 | Estrogen receptor beta antagonist | 0.093 0.077 DBMET02438 | DBMET02438 | |
| 0.007 | 0.071 | 0.046 | Estrone sulfatase inhibitor | 0.046 0.008 DBMET02438 | DBMET02438 | |
| 0.006 | 0.07 | 0.02 | Prostacyclin agonist | 0.02 0.008 DBMET02436 | DBMET02436 | |
| 0.104 | 0.168 | 0.135 | Platelet adhesion inhibitor | 0.135 0.125 DBMET02436 | DBMET02436 | |
| 0.095 | 0.168 | 0.137 | Hexokinase inhibitor | 0.137 0.095 DBMET02438 | DBMET02438 | |
| 0.038 | 0.12 | 0.074 | Prostaglandin F2 alpha antagonist | 0.074 0.028 DBMET02435 | DBMET02435 | |
| 0.112 | 0.245 | 0.215 | DNA damaging | 0.215 0.104 DBMET02438 | DBMET02438 | |
| 0.056 | 0.363 | 0.142 | Interleukin 6 antagonist | 0.142 0.102 DBMET02438 | DBMET02438 | |
| 0.004 | 0.677 | 0.052 | Oxytocin antagonist | 0.052 0.017 DBMET02438 | DBMET02438 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |